Prevention of Ventilator-Associated Pneumonia
Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Explore these free sample topics:
-- The first section of this topic is shown below --
First Things First (assess & treat for the following)
- VAP = pneumonia that develops >48 hours after initiation/onset of intubation and mechanical ventilation
- VAP is the leading cause of death amongst hospital-acquired infections, exceeding the rate of death due to central line infections, severe sepsis, and respiratory tract infections in the non-intubated patient (www.ihi.org).
- Hospital-associated pneumonia (HAP) accounts for up to 25% of all ICU-associated infections and for >50% of the antibiotics administered in the unit.
- VAP prolongs time spent on the ventilator, length of ICU stay, and length of hospital stay after discharge from the ICU (www.ihi.org).
- VAP adds an estimated cost of $40,000 to a typical hospital admission (www.ihi.org).
- Therefore, prevention of VAP is more efficacious than treatment!